Aytu BioPharma, Inc. reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported net loss was USD 2.88 million compared to USD 27.85 million a year ago. Basic loss per share from continuing operations was USD 1.2 compared to USD 21.8 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 USD | -1.86% | -0.63% | +11.62% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Aytu BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.62% | 17.65M | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.02% | 246B | |
+9.26% | 213B | |
-4.21% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Aytu BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022